571 related articles for article (PubMed ID: 34924161)
1. Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.
Yeste Fernández D; Vega Amenabar E; Coma Muñoz A; Arciniegas Vallejo L; Clemente León M; Planes-Conangla M; Iglesias Felip C; Sábado Álvarez C; Guillén Burrieza G; Campos-Martorell A
Endocrinol Diabetes Nutr (Engl Ed); 2021 Dec; 68(10):728-734. PubMed ID: 34924161
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.
Yeste Fernández D; Vega Amenabar E; Coma Muñoz A; Arciniegas Vallejo L; Clemente León M; Planes-Conangla M; Iglesias Felip C; Sábado Álvarez C; Guillén Burrieza G; Campos-Martorell A
Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; ():. PubMed ID: 33888443
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Diagnostic Performance of EU-TIRADS in Discriminating Benign from Malignant Thyroid Nodules: A Prospective Study in One Referral Center.
Kovatcheva RD; Shinkov AD; Dimitrova ID; Ivanova RB; Vidinov KN; Ivanova RS
Eur Thyroid J; 2021 Feb; 9(6):304-312. PubMed ID: 33718254
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic accuracy of ACR-TIRADS, American Thyroid Association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy.
Koc AM; Adıbelli ZH; Erkul Z; Sahin Y; Dilek I
Eur J Radiol; 2020 Dec; 133():109390. PubMed ID: 33181485
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Postoperative Outcomes and Investigating the Usefulness of EU-TIRADS Scoring in Managing Pediatric Thyroid Nodules Bethesda 3 and 4.
Kılınç Uğurlu A; Bitkay A; Gürbüz F; Karakuş E; Bayram Ilıkan G; Damar Ç; Şahin S; Kıran MM; Gülaldı N; Azılı MN; Şenel E; Ergürhan İlhan İ; Boyraz M
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):160-167. PubMed ID: 38238968
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules.
Tuli G; Munarin J; Scollo M; Quaglino F; De Sanctis L
Front Endocrinol (Lausanne); 2022; 13():1041464. PubMed ID: 36482990
[TBL] [Abstract][Full Text] [Related]
7. Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?
Yang W; Fananapazir G; LaRoy J; Wilson M; Campbell MJ
Endocr Pract; 2020 Sep; 26(9):945-952. PubMed ID: 33471698
[TBL] [Abstract][Full Text] [Related]
8. Correlation of TIRADS scoring in thyroid nodules with preoperative fine needle aspiration biopsy and postoperative specimen pathology.
Atar C; Dalcı K; Aktar Y; Totik N; Topal U; Eray İC; Akçam AT; Sakman G
Head Neck; 2024 Apr; 46(4):849-856. PubMed ID: 38197158
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
Hong HS; Lee JY
AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
[No Abstract] [Full Text] [Related]
10. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
11. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
Kim J; Shin JH; Oh YL; Hahn SY; Park KW
Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological Correlation of Thyroid Nodule Ultrasound and Cytology Using the TIRADS and Bethesda Classifications.
Singaporewalla RM; Hwee J; Lang TU; Desai V
World J Surg; 2017 Jul; 41(7):1807-1811. PubMed ID: 28251273
[TBL] [Abstract][Full Text] [Related]
13. Prediction of thyroid nodule malignancy using thyroid imaging reporting and data system (TIRADS) and nodule size.
Shayganfar A; Hashemi P; Esfahani MM; Ghanei AM; Moghadam NA; Ebrahimian S
Clin Imaging; 2020 Apr; 60(2):222-227. PubMed ID: 31927498
[TBL] [Abstract][Full Text] [Related]
14. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management.
Horvath E; Majlis S; Rossi R; Franco C; Niedmann JP; Castro A; Dominguez M
J Clin Endocrinol Metab; 2009 May; 94(5):1748-51. PubMed ID: 19276237
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance rates of the ACR-TIRADS and EU-TIRADS based on histopathological evidence.
Hekimsoy İ; Öztürk E; Ertan Y; Orman MN; Kavukçu G; Özgen AG; Özdemir M; Özbek SS
Diagn Interv Radiol; 2021 Jul; 27(4):511-518. PubMed ID: 34313236
[TBL] [Abstract][Full Text] [Related]
16. TIRADS score is of limited clinical value for risk stratification of indeterminate cytological results.
Chaigneau E; Russ G; Royer B; Bigorgne C; Bienvenu-Perrard M; Rouxel A; Leenhardt L; Belin L; Buffet C
Eur J Endocrinol; 2018 Jul; 179(1):13-20. PubMed ID: 29703794
[TBL] [Abstract][Full Text] [Related]
17. The Usefulness of the Thyroid Imaging Reporting and Data System in Determining Thyroid Malignancy.
Xie M; Gupta MK; Archibald SD; Jackson BS; Massey Ted Young JE; Zhang H
Laryngoscope; 2020 Aug; 130(8):2087-2091. PubMed ID: 31925960
[TBL] [Abstract][Full Text] [Related]
18. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
[No Abstract] [Full Text] [Related]
19. Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.
Moon HJ; Kim EK; Yoon JH; Kwak JY
Radiology; 2015 Jan; 274(1):287-95. PubMed ID: 25133852
[TBL] [Abstract][Full Text] [Related]
20. The global epidemic of thyroid cancer overdiagnosis illustrated using 18 months of consecutive nodule biopsy correlating clinical priority, ACR-TIRADS and Bethesda scoring.
Hawkins SP; Jamieson SG; Coomarasamy CN; Low IC
J Med Imaging Radiat Oncol; 2021 Jun; 65(3):309-316. PubMed ID: 33665957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
